Pharmaceuticals

Oligonucleotide Synthesis, Modification, and Purification Services Market Size, Share & Trends Analysis Report By Product (Primers, Probes, DNA Oligos, RNA Oligos, Others), By Application (Therapeutic Applications (Neurological Disorders, Rare Diseases, Other Diseases), Research Applications (PCR, Sequencing, Other Research Applications), Diagnostic Applications), Type, End-users, By Region, And By Segment Forecasts, 2025-2034

Oligonucleotide Synthesis, Modification, and Purification Services Market Size is valued at USD 4.69 billion in 2024 and is predicted to reach USD 12.27 billion by the year 2034 at a 10.02% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing focus on understanding genetic mechanisms and developing new therapies drives demand for oligonucleotide synthesis and related services. ...

Report ID: 1293  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

U.S. Assisted Living Facility Market Size, Share & Trends Analysis Distribution by Age (More than 85, 75-84, 65-74, Less than 65) and Segment Forecasts, 2025-2034

U.S. Assisted Living Facility Market Size is valued at USD 103.5 Bn in 2024 and is predicted to reach USD 182.3 Bn by the year 2034 at a 5.9% CAGR during the forecast period for 2025-2034. Assisted Living Facilities (ALFs) in the United States provide housing, personalized support services, and healthcare to older adults who require assistance with daily activities but do not need the level of care provided in nursing homes. These facilities off...

Report ID: 2616  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 175

Peptide–Drug Conjugates (PDCs) Market Size, Share & Trends Analysis Report Product Type (Radiopharmaceutical PDCs, Cytotoxic PDCs, Diagnostic PDCs, Emerging PDCs), By Therapeutic Application (Oncology, Neuroendocrine Tumors, Prostate Cancer, Solid Tumors, Hematologic Cancers, Neurological Disorders, Metabolic Diseases, Infectious Diseases), Type, Product, By Region, And By Segment Forecasts, 2025-2034

The Peptide–Drug Conjugates (PDCs) Market Size is valued at USD 3.80 Bn in 2024 and is predicted to reach USD 21.10 Bn by the year 2034 at a 18.8 % CAGR during the forecast period for 2025-2034. The emergence of Peptide–Drug Conjugates (PDCs) therapy for patients suffering from different cancers is believed to create several clinical opportunities during the forecast period. Peptide drug conjugates comprise three vital components: ...

Report ID: 1351  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Plasma Derived Therapies Market Size, Share & Trends Analysis Report by Product Type (Immunoglobulin, Coagulation Factors, Albumin), Application Type (Haemophilia, Primary Immunodeficiency Disease, Idiopathic Thrombocytopenic Purpura), Region And Segment Forecasts, 2025-2034

Plasma Derived Therapies Market Size is valued at USD 21.9 Bn in 2024 and is predicted to reach USD 42.6 Bn by the year 2034 at a 7.0% CAGR during the forecast period for 2025-2034. Immune deficiencies, bleeding problems, and genetic diseases are only some conditions that must be treated using plasma-derived therapies. Plasma fractionation, which involves separating and purifying the plasma to remove particular proteins or antibodies, is the m...

Report ID: 1936  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

ATMP Service Providers Market Size, Share & Trends Analysis Report By Type Of Service (Analytics, Quality, CMO, Logistics), By Application (GTMP, sCTMP, TEP), Region And Segment Forecasts, 2025-2034

ATMP Service Providers Market Size is valued at 16.68 Billion in 2024 and is predicted to reach 42.57 Billion by the year 2034 at a 9.9% CAGR during the forecast period of 2025-2034. Advanced Therapy Medicinal Products (ATMPs) are therapies for human consumption with an active therapeutic substance that may be based on the technology to modify a patient's genome, recombinant nucleic acids or genes, engineered tissue and substantially manipulat...

Report ID: 1228  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 150

Orphan Drugs Market Size, Share & Trends Analysis Report By Drug Type (Biological, Non-Biological), By Top Selling Drugs, By Therapy Area (Oncology, Blood, Central Nervous System, Endocrine, Respiratory, Immunomodulatory, Other Disease Types), By Region, And By Segment Forecasts, 2025-2034

Global Orphan Drugs Market Size is valued at USD 213.6 Billion in 2024 and is predicted to reach USD 669.5 Billion by the year 2034 at a 12.2% CAGR during the forecast period for 2025-2034. Orphan drugs market are recognized as the potential therapeutic market because diseases which are covered under the market are life-threatening diseases to treat disease which are very rare. More often rare diseases are genetic and present throughout a person...

Report ID: 1173  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Digital Chemical Industry Market Size, Share & Trends Analysis Report By Technology (Internet of Things (IoT), 3D Printing, Augmented Reality (AR), Virtual Reality (VR), Artificial Intelligence, Digital Twin, Others), By Verticals, By Process, By Region, And Segment Forecasts, 2025-2034

Global Digital Chemical Industry Market Size is valued at USD 19.1 Billion in 2024 and is predicted to reach USD 140.8 Billion by the year 2034 at a 22.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The adoption of Internet of Things technology in the chemical industry is a significant driver for the digital chemical industry market. Growing environmental concerns, the focus on reducin...

Report ID: 1190  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

CGRP Inhibitor Market Size, Share & Trends Analysis Report By Treatment (Preventive, Acute), By Route of Administration (Oral, Nasal, Intravenous), By End-User (Hospitals, Pharmacies, Specialty Clinics), By Region, And By Segment Forecasts, 2025-2034

Global CGRP Inhibitor Market Size is valued at USD 3.3 Bn in 2024 and is predicted to reach USD 8.5 Bn by the year 2034 at a 10.2% CAGR during the forecast period for 2025-2034. CGRP inhibitors are often used as preventative therapies for constant migraines, offering a new and focused method of treating a disorder that has an enormous adverse effect on the standard of existence for many people globally. Because of its ability to alter the proces...

Report ID: 2984  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Medication Adherence Market Size, Share & Trends Analysis Report by Type (Hardware Centric, and Software Centric), Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, and Others),, Region And Segment Forecasts, 2025-2034

Global Medication Adherence Market Size is valued at USD 4.1 billion in 2024 and is predicted to reach USD 16.2 billion by the year 2034 at a 14.9% CAGR during the forecast period for 2025-2034. The market for medication adherence is projected to see significant growth as leading companies pursue strategic initiatives such as alliances and business expansions in undeveloped areas. The aging population, increased healthcare spending, increased ph...

Report ID: 2125  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 179

Plasma Proteins Market Size, Share & Trends Analysis Report By Product Type (Coagulation Factors, Immunoglobulin, Alpha-1 Proteinase Inhibitor, and Albumin), By Clinical Application, Region And Segment Forecasts, 2025-2034.

Plasma Proteins Market Size is valued at 31.78 Billion in 2024 and is predicted to reach 70.65 Billion by the year 2034 at an 8.4% CAGR during the forecast period for 2025-2034. It is expected to shwo a CAGR of 8.4% during a forecast period of 2022-2030. Plasma is defined as a part of blood, which is a clear, straw-colored fluid residue after red platelets, white blood cells, blood cells, and other cellular components got eliminated. Huma...

Report ID: 1098  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180